UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnostic and therapeutic management of cancer of an unknown primary

European Journal of Cancer, 2003-09, Vol.39 (14), p.1990-2005

2003

Volltextzugriff (PDF)

Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes

Annals of oncology, 2012-02, Vol.23 (2), p.298-304

2012

Volltextzugriff (PDF)

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v133-v138

2015

Volltextzugriff (PDF)

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation

Journal of clinical oncology, 1997-03, Vol.15 (3), p.987-993

1997

Volltextzugriff (PDF)

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2011-09, Vol.22 (suppl_6), p.vi64-vi68

2011

Volltextzugriff (PDF)

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2164-2168

1998

Volltextzugriff (PDF)

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: A systematic literature review

Cancer treatment reviews, 2009-05, Vol.35 (3), p.221-227

2009

Volltextzugriff (PDF)

RF generation using a compact bench gyromagnetic line

Review of scientific instruments, 2022-02, Vol.93 (2)

2022

Volltextzugriff (PDF)

Paclitaxel and Gemcitabine Chemotherapy for Advanced Transitional-Cell Carcinoma of the Urothelial Tract: A Phase II Trial of the Minnie Pearl Cancer Research Network

Journal of clinical oncology, 2001-06, Vol.19 (12), p.3018-3024

2001

Volltextzugriff (PDF)

Weekly Docetaxel in the Treatment of Elderly Patients With Advanced Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial

Journal of clinical oncology, 2001-08, Vol.19 (15), p.3500-3505

2001

Volltextzugriff (PDF)

Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin

Annals of oncology, 2000-02, Vol.11 (2), p.211-215

2000

Volltextzugriff (PDF)

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1609-1614

1995

Volltextzugriff (PDF)

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide

Journal of clinical oncology, 1997-06, Vol.15 (6), p.2385-2393

1997

Volltextzugriff (PDF)

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma : A minnie pearl cancer research network Phase II trial

Cancer, 2000-07, Vol.89 (2), p.328-333

2000

Volltextzugriff (PDF)

Docetaxel (Taxotere) administered in weekly schedules

Seminars in oncology, 1999-06, Vol.26 (3 Suppl 11), p.28

Greco, F A

1999

Volltextzugriff (PDF)

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities

Journal of clinical oncology, 1997-12, Vol.15 (12), p.3464-3470

1997

Volltextzugriff (PDF)

Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim

British journal of haematology, 1998-02, Vol.100 (2), p.338-347

1998

Volltextzugriff (PDF)

Bioavailability of low-dose oral etoposide

Journal of clinical oncology, 1993-02, Vol.11 (2), p.374-377

1993

Volltextzugriff (PDF)

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

International journal of clinical oncology, 2014-06, Vol.19 (3), p.479-484

2014

Volltextzugriff (PDF)

Overexpression of Her-2 in Patients With Poorly Differentiated Carcinoma or Poorly Differentiated Adenocarcinoma of Unknown Primary Site

Journal of clinical oncology, 2000-02, Vol.18 (3), p.632-635

2000

Volltextzugriff (PDF)

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

Journal of clinical oncology, 1989-03, Vol.7 (3), p.387-391

1989

Volltextzugriff (PDF)

Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2674-2681

1996

Volltextzugriff (PDF)

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

The New England journal of medicine, 1987-06, Vol.316 (23), p.1435-1440

1987

Volltextzugriff (PDF)

Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience

Journal of clinical oncology, 1992-06, Vol.10 (6), p.912-922

1992

Volltextzugriff (PDF)

Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers

Bone marrow transplantation (Basingstoke), 1997-04, Vol.19 (7), p.671-678

1997

Volltextzugriff (PDF)

1 – 25 von 5.643

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.468)
Mit Volltextzugriff
(4.188)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.569)
Ingenta
(2.464)
EZB Electronic Journals Library
(2.163)
Ovid SocietyJournals and Single Titles
(1.574)
Elsevier ScienceDirect Journals Complete
(1.183)
Publisher or Other Site
(1.056)
IngentaConnect Journals
(979)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(590)
Wiley Online Library
(540)
Wiley Online Library
(368)
Springer Journals
(349)
IEEE Xplore
(249)
HEAL-Link subscriptions: Springer Book Series
(241)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(226)
Oxford journals
(221)
Oxford Journals 2020 Medicine
(172)
Ebook Central Perpetual and DDA
(111)
Nature Journals
(109)
eBooks on EBSCOhost
(107)
SAGE Journals
(106)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Diagnostic and therapeutic management of cancer of an unknown primary

Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: A systematic literature review

RF generation using a compact bench gyromagnetic line

Paclitaxel and Gemcitabine Chemotherapy for Advanced Transitional-Cell Carcinoma of the Urothelial Tract: A Phase II Trial of the Minnie Pearl Cancer Research Network

Weekly Docetaxel in the Treatment of Elderly Patients With Advanced Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial

Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma : A minnie pearl cancer research network Phase II trial

Docetaxel (Taxotere) administered in weekly schedules

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities

Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim

Bioavailability of low-dose oral etoposide

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

Overexpression of Her-2 in Patients With Poorly Differentiated Carcinoma or Poorly Differentiated Adenocarcinoma of Unknown Primary Site

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience

Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers

Suchergebnisse filtern